CompletedPhase 4

A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure

United States32 participantsStarted 2009-07

Plain-language summary

The purpose of this clinical research is to learn if DEFINITY® 416 will cause any adverse effects during Right Heart Catheterization. This research was requested by the FDA.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. are not pregnant and have been using an adequate and medically approved method of contraception
✓. have a negative urine pregnancy test

What they're measuring

Percent Change in Pulmonary Artery Pressure Change From 1 Minute Pre-dose to 31 - 35 Minutes Post Dose

Timeframe: 31-35 minutes minus baseline

Trial details

NCT IDNCT00918866

SponsorLantheus Medical Imaging

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2009-12

Results submitted2010-12-17

View on ClinicalTrials.gov More Pulmonary Heart Disease trials